New Treatment Target for Fibromyalgia: Inflammation in the Brain
Neuroinflammation in the brain as a therapeutic target
Brain glial activation in fibromyalgia – A multi-site positron emission tomography investigation
More evidence suggesting autoimmune component in fibromyalgia
Central Role of Dopamine in Fibromyalgia
A review of the evidence that fibromyalgia is associated with a disruption of dopaminergic neurotransmission together with a discussion of its therapeutic implications.
MAO-A Inhibition by Metaxalone Reverts IL-1β-Induced Inflammatory Phenotype in Microglial Cells
Interesting that Metaxalone has this effect, and it works well for fibromyalgia. More suggestion that there is an autoimmune component.